Elixicure CBD-Infused Pain Relief Product Receives FDA Certification
SANTA ANA, Calif., Jan. 29, 2020 /PRNewswire/ — Elixicure’s Over-The-Counter Drug Registration has been Certified by the U.S. Food and Drug Administration (FDA) for its Elixicure CBD-Infused Pain Relief products following a successful year-long process, announced Elixicure Chief of Business Development Yaniv Kotler. This marks the very first, and currently only, Over-The-Counter (OTC) Topical drug with Cannabidiol (CBD) to be registered and certified to date.